Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22210018 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
Condition: Tumors
Intervention: Drug: AMG 386
2 Active, not recruiting Phase 2 AMG 386 in Combination With Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: Paclitaxel

Indicates status has not been verified in more than two years